Side effects and potential risk factors of botulinum toxin type A intramuscular injections in knee flexion contractures of hemophiliacs

Expert Rev Hematol. 2017 Jul;10(7):587-594. doi: 10.1080/17474086.2017.1339598. Epub 2017 Jun 19.

Abstract

Knee flexion contracture (KFC) is a common complication of recurrent hemarthrosis in children and young adults with hemophilia. If the KFC is not prevented (by means of primary prophylaxis) and treated properly and early (be means of physical medicine and rehabilitation), it will become fixed. Areas covered: The aim of this article is to review the potential role of botulinum toxin type A (BTX-A) intramuscular injections for the treatment of KFC in people with hemophilia (PWH). Expert commentary: Although two recent reports have mentioned the benefits of intramuscular injections of BTX-A in PWH with KFC, the data are still scant and too preliminary. The use of intramuscular injections of BTX-A in PWH today should not be recommended until more case studies/small series (ideally well-designed clinical trials) fully demonstrate that this is safe and effective. The risks of intramuscular injections to a hemophilia patient cannot be underestimated (iatrogenic muscle hematomas and pseudotumors). This paper calls the attention of hemophilia treaters on the potential risks of this apparently interesting technique. The current use of BTX-A intramuscular injections in KFC of PWH could make no sense. Raising false expectations in these patients should be avoided.

Keywords: Hemophilia; botulinum toxin type A; flexion contracture; injections; intramuscular; knee.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Botulinum Toxins, Type A / administration & dosage*
  • Botulinum Toxins, Type A / adverse effects*
  • Contracture / drug therapy*
  • Contracture / etiology*
  • Hemophilia A / complications*
  • Humans
  • Injections, Intramuscular
  • Knee Joint / physiopathology*
  • Risk Factors
  • Treatment Outcome

Substances

  • Botulinum Toxins, Type A